BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 24506839)

  • 1. Neuro-behçet's disease in South Korea: clinical characteristics and treatment response.
    Yoon DL; Kim YJ; Koo BS; Kim YG; Lee CK; Yoo B
    Int J Rheum Dis; 2014 May; 17(4):453-8. PubMed ID: 24506839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia.
    Houman MH; Bellakhal S; Ben Salem T; Hamzaoui A; Braham A; Lamloum M; Monia SK; Ben Ghorbel I
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2015-8. PubMed ID: 23830180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging and proton magnetic resonance spectroscopy in neuro-Behçet's disease.
    Park KS; Ko HJ; Yoon CH; Park SH; Cho CS; Kim HY; Choe BY; Kim WU
    Clin Exp Rheumatol; 2004; 22(5):561-7. PubMed ID: 15485008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuro-Behçet's disease: epidemiology, clinical characteristics, and management.
    Al-Araji A; Kidd DP
    Lancet Neurol; 2009 Feb; 8(2):192-204. PubMed ID: 19161910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet's Disease.
    Yan D; Liu J; Zhang Y; Yuan W; Xu Y; Shi J; Li C; Wang Y; Peng L; Yang Y; Zhou J; Wu D; Liu Z; Zeng X; Zhang F; Zheng W; Zhao Y
    J Immunol Res; 2019; 2019():7371458. PubMed ID: 31612152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI findings in neuro-behçet's disease.
    Lee SH; Yoon PH; Park SJ; Kim DI
    Clin Radiol; 2001 Jun; 56(6):485-94. PubMed ID: 11428799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and disease course of neurological involvement in Behcet's disease: HUVAC experience.
    Bolek EC; Sari A; Kilic L; Kalyoncu U; Kurne A; Oguz KK; Topcuoglu MA; Ertenli I; Karadag O
    Mult Scler Relat Disord; 2020 Feb; 38():101512. PubMed ID: 31733425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of neuro-Behçet's disease.
    Noel N; Bernard R; Wechsler B; Resche-Rigon M; Depaz R; Le Thi Huong Boutin D; Piette JC; Drier A; Dormont D; Cacoub P; Saadoun D
    Arthritis Rheumatol; 2014 May; 66(5):1306-14. PubMed ID: 24782188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment in Brazilian patients with Behçet's disease occurs independently of neurologic manifestation.
    Dutra LA; de Souza AW; Alessi H; Guedes Bde V; Braga-Neto P; Pedroso JL; Gonçalves CR; da Rocha AJ; Bertolucci PH; Barsottini OG
    J Neurol Sci; 2013 Apr; 327(1-2):1-5. PubMed ID: 23434335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe neuro-Behcet's disease treated with a combination of immunosuppressives and a TNF-inhibitor.
    Korkmaz FN; Ozen G; Ünal AU; Kahraman Koytak P; Tuncer N; Direskeneli H
    Acta Reumatol Port; 2016; 41(4):367-371. PubMed ID: 27750273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical and radiological features and prevalence of Neuro-Behçet's Disease: A retrospective cohort multicenter study in Saudi Arabia.
    Makkawi S; Aljafari D; Alsharif R; Maaddawi H; Alwagdani A; Aljumah T; Alghweinem Z; Alshehri S; Khojah O; Halawani A; Ahmed Adas R; Abulaban A; Al Malik Y
    Mult Scler Relat Disord; 2024 May; 85():105558. PubMed ID: 38569381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological manifestations of Behçet's disease: evaluation of 40 patients treated by cyclophosphamide.
    Ait Ben Haddou EH; Imounan F; Regragui W; Mouti O; Benchakroune N; Abouqal R; Benomar A; Yahyaoui M
    Rev Neurol (Paris); 2012 Apr; 168(4):344-9. PubMed ID: 22136880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of various factors on the relapse of acute neurological attacks in Behçet's disease.
    Hirohata S; Kikuchi H; Sawada T; Nagafuchi H; Kuwana M; Takeno M; Ishigatsubo Y
    Mod Rheumatol; 2014 Nov; 24(6):961-5. PubMed ID: 24645723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of long-term outcome of chronic progressive neurological manifestations in Behcet's disease.
    Hirohata S; Kikuchi H; Sawada T; Nagafuchi H; Kuwana M; Takeno M; Ishigatsubo Y
    J Neurol Sci; 2015 Feb; 349(1-2):143-8. PubMed ID: 25601769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent aspects of Neuro-Behcet's disease].
    Hirohata S
    Brain Nerve; 2013 Nov; 65(11):1245-53. PubMed ID: 24200602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case of neuro-Behçet's disease successfully maintained a remission using infliximab for 2 years.
    Kanemaru H; Makino T; Jinnin M; Yonemitsu A; Makino K; Ihn H
    J Dermatol; 2013 Aug; 40(8):632-4. PubMed ID: 23724912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Radiographic Characteristics of Neuro-Behçet's Disease in South Korea.
    Kim SW; Kim TG; Oh J; Kim DY; Choi YC; Kim SM; Shin HY; Bang D
    J Clin Neurol; 2019 Oct; 15(4):429-437. PubMed ID: 31591829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and patterns of neurological involvement in Behcet's disease: a prospective study from Iraq.
    Al-Araji A; Sharquie K; Al-Rawi Z
    J Neurol Neurosurg Psychiatry; 2003 May; 74(5):608-13. PubMed ID: 12700303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical manifestations in Brazilian patients with neuro-Behçet's disease.
    Dutra LA; Gonçalves CR; Braga-Neto P; Pedroso JL; Gabbai AA; Barsottini OG; de Souza AW
    J Neurol; 2012 Jun; 259(6):1159-65. PubMed ID: 22169955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuro-Behçet's disease mimicking a cranial tumour.
    Senol S; Ucar M; İmamoğlu H; Yildirim A
    BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26101297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.